Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

CTQA Team Leadership

  • Our team members are recognized leaders in the field — at Dana-Farber, throughout the region, and nationwide — with specialized expertise in cellular therapy quality (improvement, assurance, and control). In addition, our team members are experts in regulatory compliance topics unique to this field, including cellular therapy clinical trials, and novel cellular manufacturing regulations.

    Julie Bryar Porter, MSc
    Vice President of Cellular Therapy Operations

    Julie leads the division's administrative, coordination, quality, and outcomes program. She focuses on quality and operations improvement efforts across platforms involved with transplantation and cellular therapies at Dana-Farber, Brigham and Women’s Hospital, and Boston Children’s Hospital. Julie works closely with clinical faculty and nursing to increase support for initiatives around clinical improvements and research.

    Bethany King
    Senior Quality Assurance Manager, Adult and Pediatric Division of Stem Cell Transplantation and Cellular Therapies

    Bethany is responsible for the quality management programs for both the adult and pediatric stem cell transplant and cellular therapy programs, as well as the marrow collection facilities. She leads a team of quality managers and specialists to support quality improvement, patient safety, and regulatory compliance for transplantation and cellular therapies. This includes management of the tri-annual Foundation for the Accreditation of Cellular Therapy (FACT) accreditation for both programs, National Marrow Donor Program (NMDP) quality assurance, performance metrics and analytics, standard operating procedures, deviation and corrective and preventative action (CAPA) management, and training and competency. She oversees the internal program auditing and corrective actions, and works closely with the processing lab and apheresis facility to monitor ongoing product quality.

    Deborah Liney, MBA, CHTC
    Quality Assurance Manager for the Division of Stem Cell Transplantation and Cellular Therapies

    Deborah specializes in quality management for stem cell transplant patients. She manages standard-of-care treatment plans, working with faculty and staff in writing SOPs and consents. Deborah conducts clinical audits to meet regulatory requirements and financial coding compliance. She also works with clinicians on quality improvement projects. Deborah also manages the Cord Blood Donation Program based at Brigham and Women’s Hospital (BWH), as well as the stem cell transplant outcomes reporting team. As a division quality manager, Deborah collaborates with other quality and operations staff to maintain quality standards and readiness for the tri-annual Foundation for the Accreditation of Cellular Therapy (FACT) accreditation and other regulatory requirements.

    Catherine Andrade
    Quality Assurance/Quality Improvement Specialist for the Division of Stem Cell Transplantation and Cellular Therapies

    Catherine specializes in quality management for the Immune Effector Cell program. She focuses on commercially approved products, REMS program compliance, and manufacturer audits. She also assists with MasterControl onboarding access to the system, ensuring users are compliant with assigned SOPs training related to REMS. She works with the clinical team, pharmacy, commercial manufacturers, the collection facility, the processing lab, and the inpatient unit to help onboard newly approved products; ensures all requirements for existing products are met; and implements quality improvements. She collaborates with quality management and other staff to ensure FACT readiness and re-accreditation, and to ensure ongoing compliance with yearly manufacturer audits.

    Lauren Bein
    Quality Assurance/Quality Improvement Specialist for Donor Services/Pediatrics and the Division of Stem Cell Transplantation and Cellular Therapies

    Lauren is responsible for the quality management for the donor services program at Dana-Farber. She assists in updating donor-specific policies, collecting and analyzing data for quality improvement projects, donor deviations tracking and corrective action, and auditing. She collaborates with quality management and other staff to ensure FACT readiness and re-accreditation, and assists with NMDP audits.

    Alexandra Kostaras
    Quality Assurance/Quality Improvement Specialist and Document Control for the Division of Stem Cell Transplantation and Cellular Therapies

    Alex is responsible for content, maintenance, and continuing validation of the electronic document system, MasterControl, providing user support, and ensuring all issues are reported and resolved with the vendor in a timely manner. She provides user access to the system and ensures that all end users know where to find controlled documents and are continuously compliant with SOP training. She collaborates with quality management and other staff to ensure FACT readiness and re-accreditation, with a focus on policies and document control. Alex also assists with clinical and other quality improvement projects, audits, and document creation.